Effect of Electrostimulation in Chronic Obstructive Pulmonary Disease (COPD)
NCT ID: NCT01167283
Last Updated: 2010-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2006-07-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To investigate whether COPD muscles can respond to stimuli in terms of changes in fiber-type distribution.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrostimulation, Skeletal Muscle Function, and Exercise Capacity in Chronic Obstructive Pulmonary Disease (COPD)
NCT00874965
Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)
NCT00677690
Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic Activation
NCT01750489
Acute Effect of Whole-body Electrical Stimulation in COPD Patients
NCT05885152
Chronic Obstructive Pulmonary Disease
NCT03577080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: To investigate whether electrostimulation program following exacerbation can modify muscle structure and function in COPD patients.
Method: We propose to conduct a controlled and randomized clinical trial comparing the efficacy of muscle electrostimulation training of the lower limbs to sham training in 15 patients with COPD. Patients are included in either 6 weeks of electrostimulation training (active treatment group) or 6 weeks of sham electrostimulation. Primary outcomes were changes in muscle structure, muscle oxidative stress and their relationship with quadriceps force and exercise tolerance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electrostimulation
Neuromuscular electrical stimulation
Electrostimulation
Electrostimulation: 35 Hz, 0.4 ms, 1 h; 5 times/week
Sham stimulation
Sham stimulation
Sham stimulation
Sham stimulation: 1 h; 5 times/week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electrostimulation
Electrostimulation: 35 Hz, 0.4 ms, 1 h; 5 times/week
Sham stimulation
Sham stimulation: 1 h; 5 times/week
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Obesity (body mass index \[BMI\] \> 30 kg/m²)
* Neuromuscular disease
* Pacemaker implantation
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Régional Universitaire Montpellier
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AEROBIE
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier OJ Jonquet, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APARD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.